Product Overview

Minirin Melt 120 mcg is a prescription tablet produced by Ferring Pharmaceuticals. It is formulated for the treatment of nocturnal enuresis (bed‑wetting) and central diabetes insipidus. Each strip contains 30, 60, or 90 tablets, each delivering 120 micrograms of the active ingredient desmopressin. The product is packaged for convenient daily use and is shipped within six to fifteen days after order confirmation.

What is Minirin Melt 120 mcg (Desmopressin)

Minirin Melt contains desmopressin, a synthetic analog of the hormone vasopressin. Desmopressin acts selectively on V2 receptors in the kidney collecting ducts, promoting water reabsorption and reducing urine output. The melt‑away formulation allows the tablet to dissolve quickly on the tongue, facilitating rapid absorption and ease of administration for patients who have difficulty swallowing conventional tablets.

Uses and Benefits

Clinically, Minirin Melt is indicated for two primary conditions: (1) primary nocturnal enuresis in children aged six years and older, and (2) central diabetes insipidus, a disorder characterized by excessive thirst and urination due to insufficient antidiuretic hormone. For bed‑wetting, the medication reduces the frequency of nighttime episodes, supporting better sleep and self‑esteem. In diabetes insipidus, it helps maintain fluid balance, decreasing the volume of dilute urine and preventing dehydration.

How It Works

The therapeutic effect of Minirin Melt stems from its interaction with the V2 receptor, which mediates the insertion of aquaporin‑2 water channels into renal tubular cells. By activating these channels, desmopressin enhances water reabsorption, concentrating the urine and decreasing nocturnal voiding. This mechanism mirrors the natural action of arginine vasopressin but with greater selectivity and a longer duration of action, allowing once‑daily dosing.

Dosage Guidelines

Patients should follow the dosing schedule prescribed by their healthcare provider. The typical starting dose for nocturnal enuresis is one 120‑microgram tablet taken at bedtime. For diabetes insipidus, dosing may be adjusted based on clinical response and serum sodium levels. The tablet should be allowed to dissolve completely on the tongue before swallowing. It is important not to crush or chew the melt‑away tablet, as this may alter its absorption profile. Dosage adjustments are made under medical supervision, and patients should never exceed the prescribed amount.

Side Effects

Like all medications, Minirin Melt can cause adverse effects. The most commonly reported side effects include headache, abdominal discomfort, nausea, and flushing. In rare cases, the medication may lead to hyponatremia — a low blood sodium concentration — particularly in pediatric patients and older adults. Signs of hyponatremia include headache, confusion, seizures, and decreased urine output. If any of these symptoms occur, medical attention should be sought promptly.

Warnings and Precautions

Minirin Melt is contraindicated in individuals with known hypersensitivity to desmopressin or any component of the formulation. Caution is advised in patients with a history of hyponatremia, severe renal impairment, or uncontrolled hypertension. The drug should be used during pregnancy only if the anticipated benefit justifies the potential risk, and breastfeeding mothers should consult their physician before use. Concurrent use of other antidiuretic agents or medications that affect fluid balance may require dose modification. Patients should inform their healthcare provider of all current medications, including over‑the‑counter drugs and herbal supplements.

Frequently Asked Questions

1. Can Minirin Melt be used by adults with bed‑wetting? Yes, while the medication is often prescribed for children, adult patients with persistent nocturnal enuresis may benefit from treatment under medical guidance.
2. How quickly does the tablet dissolve and start working? The melt‑away formulation typically dissolves within seconds, allowing the drug to be absorbed rapidly, with clinical effects usually observed within a few days to a week.
3. Is a prescription required to purchase Minirin Melt? Yes, Minirin Melt is a prescription‑only medication; a licensed healthcare professional must evaluate the patient before initiating therapy.
4. What should I do if I miss a dose? If a dose is missed, it should be taken as soon as remembered unless it is near the time of the next scheduled dose; in that case, the missed dose should be skipped and the regular dosing schedule resumed.
5. Are there any dietary restrictions while taking Minirin Melt? No specific dietary restrictions are required, but patients should maintain adequate hydration and avoid excessive fluid intake close to bedtime, which could counteract the medication’s effect.

For additional scientific details, refer to the NIH resource on diabetes insipidus, the FDA product label, and the MedlinePlus entry for comprehensive information.

Related Products

• Acto Pred Tablet (Methylprednisolone)
• Acto Pred 16 mg (Methylprednisolone)
• Acto Pred 4 mg (Methylprednisolone)
• Pentasa Granules 2g (Mesalamine)
• Pentasa Granules 1g (Mesalamine)
• Pentasa Suppository 1g (Mesalamine)
• Pentasa (Mesalamine)
• Pentasa 500 mg (Mesalamine)
• Mesalamine 500 mg (Generic)
• Mesalamine Suppository 1g (Generic)
• D-Pressin Nasal Spray 5ml (Desmopressin)
• Desmopressin 120mcg (Generic)